Nikolas Herold

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Topics

Acute Myeloid Leukemia

Top Venues

Cancer gene therapy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Virginia Amador, Marta Sureda-Gómez, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Nikolas Herold
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma. Cancer gene therapy (2024)
Nikolas Herold
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma. Cancer gene therapy 31 (6) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Virginia Amador, Marta Sureda-Gómez, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood (2024)
Nikolas Herold
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma. Cancer gene therapy 31 (6) (2024)
Nikolas Herold
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma. Cancer gene therapy 31 (6) (2024)
Nikolas Herold
A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma. Cancer gene therapy 31 (6) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Virginia Amador, Marta Sureda-Gómez, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Virginia Amador, Marta Sureda-Gómez, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood (2024)
Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, Magali Merrien, Agata Magdalena Wasik, Marta Sureda-Gómez, Virginia Amador, Henrik J Johansson, Janne Lehtiö, Beatriz Garcia-Torre, José Ignacio Martin-Subero, Nikolaos Tsesmetzis, Sijia Tao, Raymond F Schinazi, Baek Kim, Agnes L Sorteberg, Malin Wickström, Devon Sheppard, Georgios Z Rassidakis, Ian A Taylor, Birger Christensson, Elias Campo, Nikolas Herold, Birgitta Sander
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood 143 (19) (2024)
Ioanna Xagoraris, Pedro Farrajota Neves da Silva, Georgia Kokaraki, Konstantina Stathopoulou, Björn Wahlin, Anders Österborg, Nikolas Herold, Siok Bian Ng, L Jeffrey Medeiros, Elias Drakos, Birgitta Sander, George Z Rassidakis
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas. Cancers 14 (5) (2022)
Linnéa Ödborn Jönsson, Maryam Sahi, Ximena Lopez-Lorenzo, Faye Leilah Keller, Ourania N Kostopoulou, Nikolas Herold, Lars Ährlund-Richter, Shahrzad Shirazi Fard
Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines. International journal of molecular sciences 22 (7) (2021)
Nikolas Herold
Pharmacological strategies to overcome treatment resistance in acute myeloid leukemia: increasing leukemic drug exposure by targeting the resistance factor SAMHD1 and the toxicity factor Top2β. Expert opinion on drug discovery 16 (1) (2020)
Ingrid Lilienthal, Nikolas Herold
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies. International journal of molecular sciences 21 (18) (2020)
Sean G Rudd, Nikolaos Tsesmetzis, Kumar Sanjiv, Cynthia Bj Paulin, Lakshmi Sandhow, Juliane Kutzner, Ida Hed Myrberg, Sarah S Bunten, Hanna Axelsson, Si Min Zhang, Azita Rasti, Petri Mäkelä, Si'Ana A Coggins, Sijia Tao, Sharda Suman, Rui M Branca, Georgios Mermelekas, Elisée Wiita, Sun Lee, Julian Walfridsson, Raymond F Schinazi, Baek Kim, Janne Lehtiö, Georgios Z Rassidakis, Katja Pokrovskaja Tamm, Ulrika Warpman-Berglund, Mats Heyman, Dan Grandér, Sören Lehmann, Thomas Lundbäck, Hong Qian, Jan-Inge Henter, Michaela Arndt, Thomas Helleday, Nikolas Herold
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy. EMBO molecular medicine 12 (3) (2020)
Nikolas Herold
Overexpression of the Interferon-Inducible Isoform 4 of NCOA7 Dissects the Entry Route of Enveloped Viruses and Demonstrates that HIV Enters Cells via Fusion at the Plasma Membrane. Viruses 11 (2) (2019)
Nikolaos Tsesmetzis, Cynthia B J Paulin, Sean G Rudd, Nikolas Herold
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism. Cancers 10 (7) (2018)
Nikolas Herold, Sean G Rudd, Kumar Sanjiv, Juliane Kutzner, Julia Bladh, Cynthia B J Paulin, Thomas Helleday, Jan-Inge Henter, Michaela Arndt
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites. Cell cycle (Georgetown, Tex.) 16 (11) (2017)
Nikolas Herold, Sean G Rudd, Linda Ljungblad, Kumar Sanjiv, Ida Hed Myrberg, Cynthia B J Paulin, Yaser Heshmati, Anna Hagenkort, Juliane Kutzner, Brent D G Page, José M Calderón-Montaño, Olga Loseva, Ann-Sofie Jemth, Lorenzo Bulli, Hanna Axelsson, Bianca Tesi, Nicholas C K Valerie, Andreas Höglund, Julia Bladh, Elisée Wiita, Mikael Sundin, Michael Uhlin, Georgios Rassidakis, Mats Heyman, Katja Pokrovskaja Tamm, Ulrika Warpman-Berglund, Julian Walfridsson, Sören Lehmann, Dan Grandér, Thomas Lundbäck, Per Kogner, Jan-Inge Henter, Thomas Helleday, Michaela Arndt
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies. Nature medicine 23 (2) (2017)
Sean G Rudd, Michaela Arndt, Nikolas Herold
SAMHD1 is a barrier to antimetabolite-based cancer therapies. Molecular & cellular oncology 4 (2) (2017)